Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy

Soudeh Ghafouri-Fard1, Mohammad-Hossein Modarressi

  • 1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran. ghafourifard@razi.tums.ac.ir

Immunotherapy
|December 14, 2011
PubMed

Insights

Cancer-testis (CT) genes, normally found only in testes, can become immunogenic when expressed in tumors. This makes CT genes promising targets for novel cancer vaccines and immunotherapies, particularly for brain tumors and recurring cancers.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Cancer-testis (CT) genes exhibit restricted expression in normal tissues, primarily the testis.
  • The testis is an immune-privileged site, shielding germ cells from immune surveillance.
  • Aberrant expression of CT genes in tumors can render them immunogenic, presenting therapeutic opportunities.

Purpose of the Study:

  • To explore the potential of cancer-testis (CT) genes as targets for cancer immunotherapy.
  • To investigate the role of CT gene expression in brain tumors and cancer stem cells.
  • To evaluate the feasibility of polyvalent antitumor vaccines based on CT gene antibodies.

Main Methods:

  • Analysis of CT gene expression patterns in normal tissues and various tumor types.
  • Assessment of CT gene expression in brain tumors and cancer stem cells.
  • Review of existing data on antibodies against CT genes in cancer patients.

Main Results:

  • CT genes are expressed in a significant proportion of brain tumors, indicating potential immunotherapeutic targets.
  • CT gene expression in cancer stem cells suggests a role in tumor recurrence and metastasis.
  • Antibodies against CT genes are present in patients with advanced cancers, supporting vaccine development.

Conclusions:

  • Cancer-testis genes represent promising targets for developing novel immunotherapies and vaccines against various cancers.
  • Targeting CT genes in brain tumors and cancer stem cells could offer new treatment strategies for difficult-to-treat malignancies.
  • The presence of anti-CT gene antibodies supports the potential of polyvalent vaccines for broad antitumor efficacy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...